Glanbia Plc ADR (OTCMKTS:GLAPY - Get Free Report) was the target of a significant increase in short interest in March. As of March 13th, there was short interest totaling 97 shares, an increase of 47.0% from the February 26th total of 66 shares. Approximately 0.0% of the company's stock are sold short. Based on an average daily volume of 9 shares, the days-to-cover ratio is currently 10.8 days.
Wall Street Analyst Weigh In
GLAPY has been the topic of several recent analyst reports. Kepler Capital Markets downgraded shares of Glanbia from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, March 4th. Zacks Research raised shares of Glanbia to a "hold" rating in a research note on Tuesday, March 3rd. Two analysts have rated the stock with a Hold rating, According to data from MarketBeat, Glanbia currently has an average rating of "Hold".
Read Our Latest Stock Report on Glanbia
Glanbia Stock Performance
GLAPY stock remained flat at $98.24 during trading on Friday. The company had a trading volume of 2 shares, compared to its average volume of 1. The stock has a 50 day moving average price of $96.66 and a 200-day moving average price of $88.16. The company has a debt-to-equity ratio of 0.38, a current ratio of 1.36 and a quick ratio of 0.89. Glanbia has a 1-year low of $52.40 and a 1-year high of $99.00.
About Glanbia
(
Get Free Report)
Glanbia plc is a global nutrition company headquartered in Kilkenny, Ireland. The company operates through two principal divisions: Performance Nutrition and Glanbia Nutritionals. Performance Nutrition develops and markets sports and lifestyle nutrition products, including powders, bars and ready-to-drink beverages for athletes and fitness enthusiasts. Glanbia Nutritionals supplies dairy-based ingredients, specialty cheeses, whey proteins, nutrient premixes and functional food solutions to food, beverage and supplement manufacturers worldwide.
Glanbia was formed in 1997 through the merger of Avonmore Food plc and Waterford Foods plc.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Glanbia, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Glanbia wasn't on the list.
While Glanbia currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.